Intuitive Surgical, Inc. (NASDAQ:ISRG) CFO Sells $158,710.00 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) CFO Jamie Samath sold 269 shares of Intuitive Surgical stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $590.00, for a total value of $158,710.00. Following the transaction, the chief financial officer now directly owns 3,282 shares in the company, valued at approximately $1,936,380. This trade represents a 7.58 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Jamie Samath also recently made the following trade(s):

• On Wednesday, January 29th, Jamie Samath sold 94 shares of Intuitive Surgical stock. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34.
• On Tuesday, December 10th, Jamie Samath sold 270 shares of Intuitive Surgical stock. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50.
• On Friday, November 29th, Jamie Samath sold 188 shares of Intuitive Surgical stock. The shares were sold at an average price of $539.00, for a total value of $101,332.00.
• On Tuesday, November 26th, Jamie Samath sold 108 shares of Intuitive Surgical stock. The stock was sold at an average price of $542.06, for a total value of $58,542.48.

Intuitive Surgical Trading Down 0.3 %

Intuitive Surgical stock opened at $589.61 on Thursday. The company has a market capitalization of $210.01 billion, a price-to-earnings ratio of 91.98, a PEG ratio of 5.67 and a beta of 1.39. The stock’s 50 day moving average is $556.91 and its 200-day moving average is $516.98. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the company. Jefferies Financial Group raised their target price on Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Robert W. Baird lifted their target price on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. Mizuho boosted their price target on shares of Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Finally, The Goldman Sachs Group set a $604.00 price target on shares of Intuitive Surgical in a research report on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average target price of $613.10.

Institutional Investors Weigh In On Intuitive Surgical

A number of institutional investors have recently modified their holdings of the business. ExodusPoint Capital Management LP raised its stake in Intuitive Surgical by 1,556.7% in the fourth quarter. ExodusPoint Capital Management LP now owns 65,176 shares of the medical equipment provider’s stock valued at $34,019,000 after purchasing an additional 61,242 shares in the last quarter. Grant Private Wealth Management Inc bought a new position in Intuitive Surgical in the fourth quarter valued at about $1,801,000. Spahn Wealth & Retirement LLC acquired a new stake in Intuitive Surgical during the 4th quarter worth approximately $4,343,000. Arete Wealth Advisors LLC grew its stake in shares of Intuitive Surgical by 78.3% in the fourth quarter. Arete Wealth Advisors LLC now owns 1,908 shares of the medical equipment provider’s stock worth $996,000 after purchasing an additional 838 shares during the last quarter. Finally, Motley Fool Asset Management LLC increased its stake in shares of Intuitive Surgical by 18.3% in the fourth quarter. Motley Fool Asset Management LLC now owns 19,248 shares of the medical equipment provider’s stock valued at $10,047,000 after buying an additional 2,983 shares during the period. Institutional investors own 83.64% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.